Pregnancy in congenital myasthenic syndrome

Journal of Neurology

Volumn 260, Issue 3, 2013, Pages 815-819

  Servais, L ^a   Baudoin, H ^a   Zehrouni, K ^a   Richard, P ^a   Sternberg, D ^a   Fournier, E ^a   Eymard, B ^a   Stojkovic, T ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Congenital Myasthenia; Delivery; Neuromuscular junction; Outcome; Pregnancy

Indexed keywords

CHRNA1 PROTEIN; CHRND PROTEIN; CHRNE PROTEIN; COLQ PROTEIN; DOK7 PROTEIN; GFPT1 PROTEIN; PROTEIN; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONGENITAL MYASTHENIC SYNDROME; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MUTATION; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; PULMONARY VALVE ATRESIA;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MIDDLE AGED; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 84876480836     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6709-x     Document Type: Article

References (16)

1. Belaya K, Finlayson S, Slater CR et al (2012) Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet 91:193-201
2. Engel AG (2012) Current status of the congenital myasthenic syndromes. Neuromuscul Disord 22:99-111
3. Norwood F, Rudnik-Schoneborn S (2012) 179th ENMC international workshop: pregnancy in women with neuromuscular disorders 5-7 November 2010, Naarden, The Netherlands. Neuromuscul Disord 22:183-190
4. Ferrero S, Esposito F, Biamonti M, Bentivoglio G, Ragni N (2008) Myasthenia gravis during pregnancy. Expert Rev Neurother 8:979-988
5. Wargon I, Richard P, Kuntzer T et al (2012) Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations. Neuromuscul Disord 22:318-324
6. Milone M, Wang HL, Ohno K et al (1997) Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 17:5651-5665
7. Chevessier F, Faraut B, Ravel-Chapuis A et al (2004) MUSK, a new target for mutations causing congenital myasthenic syndrome. Hum Mol Genet 13:3229-3240
8. Huze C, Bauche S, Richard P et al (2009) Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am J Hum Genet 85:155-167
9. Outteryck O, Richard P, Lacour A et al (2009) Novel epsilon subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome. J Neurol Neurosurg Psychiatry 80:450-451
10. Ben Ammar A, Petit F, Alexandri N et al (2010) Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. J Neurol 257:754-766
11. Oosterhuis HJ, Newsom-Davis J, Wokke JH et al (1987) The slow channel syndrome. Two new cases. Brain 110:1061-1079
12. Wu KH, Tobias ML, Kelley DB (2001) Estrogen and laryngeal synaptic strength in Xenopus laevis: opposite effects of acute and chronic exposure. Neuroendocrinology 74:22-32
13. Prioux F, Mazuy M, Barbieri B (2010) L'évolution démographique récente en France: les adultes vivent moins souvent en couple. Population-F 65:421-474
14. McDonald SD, Lutsiv O, Dzaja N, Duley L (2012) A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynaecol Obstet 118:90-96
15. Lewis CA (1984) Divalent cation effects on acetylcholine-activated channels at the frog neuromuscular junction. Cell Mol Neurobiol 4:273-284
16. Bashuk RG, Krendel DA (1990) Myasthenia gravis presenting as weakness after magnesium administration. Muscle Nerve 13:708-712